发明名称 |
SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia. |
摘要 |
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. |
申请公布号 |
AP201105795(D0) |
申请公布日期 |
2011.08.31 |
申请号 |
AP20110005795 |
申请日期 |
2010.02.11 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
MARK MICHAEL;THOMAS LEO;BROEDL ULI |
分类号 |
A61K31/7034;A61P3/04;A61P3/06;A61P3/10 |
主分类号 |
A61K31/7034 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|